Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary Interventions

Circulation - United States
doi 10.1161/circulationaha.105.536268
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Definition of Restenosis After Percutaneous Transluminal Coronary Angioplasty: A Quickly Evolving Concept

Journal of Interventional Cardiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
1991English

Restenosis After Percutaneous Transluminal Coronary Angioplasty in the Elderly. Risk Factor Analysis.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1995English

Stress Testing After Percutaneous Coronary Interventions: A Population-Based Study

CMAJ Open
2017English

Angiotensinogen M235T Gene Polymorphism and Recurrent Restenosis After Repeated Percutaneous Transluminal Coronary Angiography

Clinical Science
Medicine
2002English

Glycaemic Control and Restenosis After Percutaneous Coronary Interventions in Patients With Diabetes Mellitus: A Report From the Insulin Diabetes Angioplasty Study

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2009English

Candidate Genetic Markers and the Risk of Restenosis After Coronary Angioplasty

Clinical Science
Medicine
2004English

Arrhythmic Complications During Percutaneous Coronary Interventions

Cardiologia Croatica
Cardiovascular MedicineCardiology
2020English

Predictors of Long-Term Fatal Cardiovascular Events After Planned Percutaneous Coronary Interventions

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Interleukin 10: A New Risk Marker for the Development of Restenosis After Percutaneous Coronary Intervention

Genes and Immunity
ImmunologyGenetics
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy